The study and treatment of the myelodysplastic patient.
Sanz
M A
MA
Bennett
J M
JM
Vallespí
T
T
Hoelzer
D
D
D001853:Bone Marrow / Q000473:pathology; D002869:Chromosome Aberrations; D002986:Clinical Trials as Topic; D002999:Clone Cells / Q000473:pathology; D016298:Hematopoietic Cell Growth Factors / Q000627:therapeutic use; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D009190:Myelodysplastic Syndromes / Q000145:classification / Q000235:genetics / Q000401:mortality / Q000473:pathology / Q000628:therapy; D009857:Oncogenes; D011379:Prognosis; D011994:Recombinant Proteins / Q000627:therapeutic use
D016298:Hematopoietic Cell Growth Factors; D007155:Immunologic Factors; D011994:Recombinant Proteins